Molecular epidemiology of acquired-metallo-beta-lactamase-producing bacteria in Poland. 2006

Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
National Institute of Public Health, ul. Chełmska 30/34, 00-725 Warsaw, Poland.

We have analyzed 40 metallo-beta-lactamase (MBL)-producing isolates of Pseudomonas aeruginosa (n = 38), Pseudomonas putida (n = 1), and Acinetobacter genospecies 3 (n = 1) from 17 hospitals in 12 cities in Poland that were identified in 2000 to 2004. Pulsed field gel electrophoresis typing classified the P. aeruginosa isolates into eight types, with two types differentiated further into subtypes. Each of the types was specific either to a given center or to several hospitals of the same or neighboring geographic area. Almost all of the organisms produced beta-lactamase VIM-2; the only exceptions were several P. aeruginosa isolates from two centers which expressed VIM-4. The bla(VIM) genes resided exclusively within class 1 integrons, and these were located in either chromosomal or plasmid DNA. PCR-restriction fragment length polymorphism study of the variable regions of the integrons, followed by DNA sequencing, revealed the presence of eight different, mostly novel gene cassette arrays, six of which contained bla(VIM-2) and two of which contained bla(VIM-4). The occurrence of the integron variants correlated well with the geographic distribution of the MBL-producing organisms, and this suggested that their emergence in particular parts of the country had been likely due to a number of independent events. The following regional dissemination of MBL producers could be attributed to various phenomena, including their clonal spread, horizontal transmission of resistance determinants, or both. All of the data collected in this study revealed that even at this early stage of detection, the epidemiological situation concerning MBL producers in Poland has already been complex and very dynamic.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011044 Poland A country in central Europe, east of Germany. The capital is Warsaw. Polish People's Republic,Republic of Poland
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D004269 DNA, Bacterial Deoxyribonucleic acid that makes up the genetic material of bacteria. Bacterial DNA
D000150 Acinetobacter A genus of gram-negative bacteria of the family MORAXELLACEAE, found in soil and water and of uncertain pathogenicity. Herellea,Mima
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001618 beta-Lactamases Enzymes found in many bacteria which catalyze the hydrolysis of the amide bond in the beta-lactam ring. Well known antibiotics destroyed by these enzymes are penicillins and cephalosporins. beta-Lactamase,beta Lactamase,beta Lactamases

Related Publications

Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
April 2001, Nihon rinsho. Japanese journal of clinical medicine,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
February 2007, Nihon rinsho. Japanese journal of clinical medicine,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
December 2006, Antimicrobial agents and chemotherapy,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
January 2010, Anestezjologia intensywna terapia,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
August 2021, The Journal of antimicrobial chemotherapy,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
February 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
February 2012, Nihon rinsho. Japanese journal of clinical medicine,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
February 1990, Antimicrobial agents and chemotherapy,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
February 2007, Journal of clinical microbiology,
Janusz Fiett, and Anna Baraniak, and Agnieszka Mrówka, and Malgorzata Fleischer, and Zuzanna Drulis-Kawa, and Łukasz Naumiuk, and Alfred Samet, and Waleria Hryniewicz, and Marek Gniadkowski
October 2013, Avicenna journal of medicine,
Copied contents to your clipboard!